Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PN2034 in insulin-dependent type 2 diabetes
NCT00110864Phase 2Completed
- Sponsor
- Wellstat Therapeutics Corporation
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PN-2034 in type 2 diabetes mellitus (T2DM), sponsored by Wellstat Therapeutics Corporation. Started May 2005; status: completed.
02
Drugs
PN-2034
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00110864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00110864.